Pharming Group N.V. (PHAR)
USD 7.66
(-0.39%)
USD 7.66
(-0.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 220.1 Million USD | 17.04% |
| 2022 | 188.06 Million USD | 10.84% |
| 2021 | 169.67 Million EUR | -16.44% |
| 2020 | 203.05 Million EUR | 22.76% |
| 2019 | 165.41 Million EUR | 28.02% |
| 2018 | 129.2 Million EUR | 39.55% |
| 2017 | 92.58 Million EUR | 686.73% |
| 2016 | 11.76 Million EUR | 78.57% |
| 2015 | 6.59 Million EUR | -69.48% |
| 2014 | 21.59 Million EUR | 172.83% |
| 2013 | 7.91 Million EUR | -5.69% |
| 2012 | 8.39 Million EUR | 1319.46% |
| 2011 | -688.22 Thousand EUR | -207.36% |
| 2010 | 641.04 Thousand EUR | -59.18% |
| 2009 | 1.57 Million EUR | 69.88% |
| 2008 | 924.35 Thousand EUR | 102.57% |
| 2007 | -35.89 Million EUR | -18602.9% |
| 2006 | 194.01 Thousand EUR | 103.41% |
| 2005 | -5.69 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 47.08 Million USD | -29.81% |
| 2024 Q2 | 66.03 Million USD | 40.24% |
| 2024 Q3 | 68.22 Million USD | 3.31% |
| 2023 FY | 220.1 Million USD | 17.04% |
| 2023 Q1 | 38.46 Million USD | -20.44% |
| 2023 Q4 | 67.09 Million USD | 14.95% |
| 2023 Q2 | 49.17 Million USD | 27.83% |
| 2023 Q3 | 58.36 Million USD | 18.7% |
| 2022 Q3 | 51.85 Million USD | 12.44% |
| 2022 FY | 188.06 Million USD | 10.84% |
| 2022 Q2 | 46.11 Million USD | 10.49% |
| 2022 Q1 | 41.74 Million USD | 2.16% |
| 2022 Q4 | 48.34 Million USD | -6.77% |
| 2021 Q1 | 37.55 Million EUR | -39.57% |
| 2021 Q2 | 45.07 Million EUR | 20.04% |
| 2021 Q3 | 43.79 Million EUR | -2.85% |
| 2021 FY | 169.67 Million EUR | -16.44% |
| 2021 Q4 | 40.85 Million EUR | -6.71% |
| 2020 FY | 203.05 Million EUR | 22.76% |
| 2020 Q1 | 48.42 Million EUR | 0.35% |
| 2020 Q4 | 62.14 Million EUR | 18.69% |
| 2020 Q3 | 52.35 Million EUR | 30.48% |
| 2020 Q2 | 40.12 Million EUR | -17.13% |
| 2019 Q2 | 42.68 Million EUR | 27.53% |
| 2019 FY | 165.41 Million EUR | 28.02% |
| 2019 Q1 | 33.46 Million EUR | 0.17% |
| 2019 Q3 | 41 Million EUR | -3.94% |
| 2019 Q4 | 48.25 Million EUR | 17.69% |
| 2018 FY | 129.2 Million EUR | 39.55% |
| 2018 Q4 | 33.41 Million EUR | -12.07% |
| 2018 Q3 | 38 Million EUR | 37.54% |
| 2018 Q2 | 27.63 Million EUR | -8.38% |
| 2018 Q1 | 30.15 Million EUR | -14.51% |
| 2017 FY | 92.58 Million EUR | 686.73% |
| 2017 Q2 | 16.16 Million EUR | 9.91% |
| 2017 Q3 | 26.43 Million EUR | 63.54% |
| 2017 Q4 | 35.27 Million EUR | 33.44% |
| 2017 Q1 | 14.7 Million EUR | 160.58% |
| 2016 Q3 | 2.48 Million EUR | 32.8% |
| 2016 FY | 11.76 Million EUR | 78.57% |
| 2016 Q1 | 1.76 Million EUR | 41.91% |
| 2016 Q4 | 5.64 Million EUR | 126.95% |
| 2016 Q2 | 1.87 Million EUR | 6.13% |
| 2015 Q2 | 2.39 Million EUR | 183.94% |
| 2015 FY | 6.59 Million EUR | -69.48% |
| 2015 Q1 | 842.51 Thousand EUR | -95.81% |
| 2015 Q4 | 1.24 Million EUR | -41.13% |
| 2015 Q3 | 2.11 Million EUR | -11.7% |
| 2014 Q1 | 277.81 Thousand EUR | -35.19% |
| 2014 FY | 21.59 Million EUR | 172.83% |
| 2014 Q4 | 20.09 Million EUR | 4009.18% |
| 2014 Q2 | 730.39 Thousand EUR | 162.91% |
| 2014 Q3 | 489.09 Thousand EUR | -33.04% |
| 2013 FY | 7.91 Million EUR | -5.69% |
| 2013 Q1 | 619.81 Thousand EUR | -93.56% |
| 2013 Q2 | 5.76 Million EUR | 829.57% |
| 2013 Q4 | 428.68 Thousand EUR | -61.21% |
| 2013 Q3 | 1.1 Million EUR | -80.82% |
| 2012 Q3 | 367.55 Thousand EUR | 116.36% |
| 2012 FY | 8.39 Million EUR | 1319.46% |
| 2012 Q1 | 645.65 Thousand EUR | 139.36% |
| 2012 Q4 | 9.62 Million EUR | 2519.09% |
| 2012 Q2 | -2.24 Million EUR | -448.04% |
| 2011 Q2 | -415.8 Thousand EUR | -156.96% |
| 2011 Q3 | 637.93 Thousand EUR | 253.42% |
| 2011 Q4 | -1.64 Million EUR | -357.13% |
| 2011 FY | -688.22 Thousand EUR | -207.36% |
| 2011 Q1 | 729.95 Thousand EUR | 583.38% |
| 2010 FY | 641.04 Thousand EUR | -59.18% |
| 2010 Q4 | -151.01 Thousand EUR | -141.81% |
| 2010 Q3 | 361.14 Thousand EUR | 67.51% |
| 2010 Q2 | 215.59 Thousand EUR | -22.42% |
| 2010 Q1 | 277.89 Thousand EUR | -64.94% |
| 2009 Q4 | 792.72 Thousand EUR | 195.82% |
| 2009 Q3 | 267.97 Thousand EUR | -23.49% |
| 2009 Q2 | 350.26 Thousand EUR | 153.86% |
| 2009 Q1 | 137.97 Thousand EUR | 0.0% |
| 2009 FY | 1.57 Million EUR | 69.88% |
| 2008 FY | 924.35 Thousand EUR | 102.57% |
| 2007 FY | -35.89 Million EUR | -18602.9% |
| 2006 FY | 194.01 Thousand EUR | 103.41% |
| 2005 FY | -5.69 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -478.84% |
| Alkermes plc | 1.37 Billion USD | 83.989% |
| Agenus Inc. | 139.61 Million USD | -57.651% |
| Aptorum Group Limited | -1.11 Million USD | 19845.794% |
| Ardelyx, Inc. | 106.66 Million USD | -106.358% |
| Dyadic International, Inc. | 922.95 Thousand USD | -23747.698% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -945.079% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 125986.653% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1747.75% |
| Novavax, Inc. | 639.93 Million USD | 65.605% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 569.916% |
| Pyxis Oncology, Inc. | -2 Million USD | 11105.2% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 42694.234% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1055.826% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 498208.084% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 41865.465% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 324.1% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -27344.389% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 268519.512% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -62.716% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2696.392% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 327.028% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 85.499% |
| AlloVir, Inc. | -398 Thousand USD | 55402.513% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 8.57% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -51811.321% |
| Bicycle Therapeutics plc | -129.52 Million USD | 269.938% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -183320.0% |
| ChromaDex Corporation | 50.78 Million USD | -333.446% |
| Chimerix, Inc. | 324 Thousand USD | -67833.333% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 806.194% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 383.646% |
| CRISPR Therapeutics AG | 240.95 Million USD | 8.654% |
| Precision BioSciences, Inc. | 40.47 Million USD | -443.843% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 324.223% |
| Fortress Biotech, Inc. | 57.85 Million USD | -280.454% |
| Fortress Biotech, Inc. | 57.85 Million USD | -280.454% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1227.767% |
| ImmuCell Corporation | 4.39 Million USD | -4906.592% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 307.405% |
| Immix Biopharma, Inc. | -5468.00 USD | 4025410.9% |
| Incyte Corporation | 3.44 Billion USD | 93.603% |
| Innoviva, Inc. | 261.06 Million USD | 15.69% |
| IO Biotech, Inc. | -756 Thousand USD | 29214.286% |
| Jaguar Health, Inc. | 7.72 Million USD | -2749.612% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 33248.193% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -83.798% |
| ContextLogic Inc. | 59 Million USD | -273.058% |
| MiMedx Group, Inc. | 266.84 Million USD | 17.516% |
| MEI Pharma, Inc. | 49.32 Million USD | -346.214% |
| NextCure, Inc. | -3.68 Million USD | 6074.593% |
| Onconetix, Inc. | -1.12 Million USD | 19627.221% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 859.818% |
| Opthea Limited | 21.72 Thousand USD | -1013270.166% |
| Psyence Biomedical Ltd. | -240.00 USD | 91710100.0% |
| Vaxcyte, Inc. | -75 Million USD | 393.472% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 384051.436% |
| Precigen, Inc. | 106 Thousand USD | -207545.283% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -42638.641% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -21714.073% |
| PureTech Health plc | -1.6 Million USD | 13830.755% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -100.51% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 221.331% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 585.613% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1101.064% |
| Acelyrin, Inc. | -115 Thousand USD | 191494.783% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2189971.655% |
| Summit Therapeutics Inc. | -2.05 Million USD | 10836.78% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 38647.11% |
| Senti Biosciences, Inc. | -2.68 Million USD | 8303.653% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5333.325% |
| Elevation Oncology, Inc. | -39 Thousand USD | 564469.231% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 4687.411% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 5683.494% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -655.618% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -44275.806% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 400289.091% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -111.437% |
| Seer, Inc. | 7.02 Million USD | -3032.261% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -4927.501% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -921.601% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 185855.88% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 153695.579% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -36041.872% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -82.698% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 29.83% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4402180.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -8451.049% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 433887.939% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -648.984% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 94972.414% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 44836.585% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3200.93% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 46482.113% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2116484.615% |
| Soligenix, Inc. | 97.31 Thousand USD | -226086.145% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2136.303% |
| Kura Oncology, Inc. | -849 Thousand USD | 26025.088% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 428.004% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 149830.612% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -122.24% |
| Autolus Therapeutics plc | -4.86 Million USD | 4622.375% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -431.832% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 131114.286% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -132.366% |
| GRI Bio, Inc. | 10.84 Million USD | -1930.292% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -8565.56% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2633.717% |
| IGM Biosciences, Inc. | -211.66 Million USD | 203.989% |
| INmune Bio, Inc. | 155 Thousand USD | -141902.581% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -255.356% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14712.316% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 34042.886% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 751975.384% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -54652.239% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 11127.255% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 70420.767% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -133.01% |
| Verastem, Inc. | -62 Thousand USD | 355106.452% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -8939.179% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 84431.034% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -7171.358% |
| Histogen Inc. | 3.76 Million USD | -5739.851% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -38100.629% |
| Surrozen, Inc. | -27.23 Million USD | 908.314% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4184.32% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 18367.711% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 958.206% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -997.666% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 11116463.636% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3528.234% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 327972.369% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -42.194% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -150862.963% |
| Apollomics, Inc. | 127 Thousand USD | -173210.236% |
| Amarin Corporation plc | 165.54 Million USD | -32.96% |
| Mesoblast Limited | -9.81 Million USD | 2342.527% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1233.479% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 299.209% |
| Synaptogenix, Inc. | -6347.00 USD | 3467943.075% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 431676.471% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -36.401% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 87.477% |
| Better Therapeutics, Inc. | -2.72 Million USD | 8165.372% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 296.239% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 34.896% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1929482.889% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 3616.038% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 19964.982% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2907.707% |
| Insmed Incorporated | 239.63 Million USD | 8.15% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -6051.593% |
| OmniAb, Inc. | 14.66 Million USD | -1400.675% |
| Alector, Inc. | -95.05 Million USD | 331.559% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -75.213% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 606.417% |
| Zai Lab Limited | 170.9 Million USD | -28.789% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -168.823% |
| Aura Biosciences, Inc. | -1.29 Million USD | 17096.448% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -169210.769% |
| Immunic, Inc. | -111 Thousand USD | 198391.892% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1288.318% |
| Veracyte, Inc. | 248.14 Million USD | 11.301% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.149% |
| FibroGen, Inc. | 128.9 Million USD | -70.75% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 39025631.915% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1986.57% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 93.524% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -56482.005% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 38.059% |
| TG Therapeutics, Inc. | 219.1 Million USD | -0.455% |
| Galecto, Inc. | -830 Thousand USD | 26618.554% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 15991.986% |
| Fortrea Holdings Inc. | 424 Million USD | 48.089% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 355.439% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 38919.048% |
| XBiotech Inc. | -1.74 Million USD | 12720.642% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 19964.982% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 573.637% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 391.397% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -199.857% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1209.909% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 43.424% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 543.338% |
| Vaxxinity, Inc. | -2.23 Million USD | 9952.462% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 32.639% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2043.722% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -800.184% |
| NexImmune, Inc. | -1.02 Million USD | 21574.148% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4075900.0% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3197.589% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.052% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 329463.88% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6298.367% |
| Ainos, Inc. | -253.73 Thousand USD | 86846.304% |
| Pluri Inc. | 322 Thousand USD | -68255.28% |
| Prothena Corporation plc | -129.2 Million USD | 270.358% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -336.507% |
| Celularity Inc. | 6.75 Million USD | -3158.386% |
| Rallybio Corporation | -150 Thousand USD | 146836.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 775.021% |
| MeiraGTx Holdings plc | 287 Thousand USD | -76591.289% |
| Omeros Corporation | -69.77 Million USD | 415.43% |
| Humacyte, Inc. | -76.55 Million USD | 387.53% |
| Immunocore Holdings plc | 248.39 Million USD | 11.388% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1551.012% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -252.833% |
| Blueprint Medicines Corporation | 236.58 Million USD | 6.966% |
| CalciMedica, Inc. | -58 Thousand USD | 379589.655% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 15535.063% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -657.543% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 7839.241% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 813.118% |
| Pulmatrix, Inc. | -8.22 Million USD | 2777.664% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 18912.308% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 55263.91% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 155.192% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -7830.004% |
| Cytokinetics, Incorporated | -322.59 Million USD | 168.23% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -25430.997% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 64646.628% |
| Vor Biopharma Inc. | -3.49 Million USD | 6403.093% |
| Roivant Sciences Ltd. | 109.23 Million USD | -101.496% |
| Evogene Ltd. | 1.39 Million USD | -15632.952% |
| ProKidney Corp. | -3.16 Million USD | 7045.535% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 601.239% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3109.917% |
| CorMedix Inc. | -205.56 Thousand USD | 107174.265% |
| BioLineRx Ltd. | 1.1 Million USD | -19764.982% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 379.778% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 667081.818% |
| Atai Life Sciences N.V. | -5000.00 USD | 4402180.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 180721.866% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 229375.0% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 15946.22% |
| Sagimet Biosciences Inc. | 2 Million USD | -10905.2% |
| MediciNova, Inc. | 979.7 Thousand USD | -22366.355% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 361.037% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 232878.806% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1162.239% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 9.991% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5339.324% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 74.768% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2863.964% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 71101.29% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1834300.0% |
| Absci Corporation | -41.84 Million USD | 625.948% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4402180.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 388.196% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 9043.681% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -2.98% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 23490.436% |
| Allakos Inc. | -6.14 Million USD | 3684.172% |
| Imunon, Inc. | -720 Thousand USD | 30669.788% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 419.01% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 53.749% |
| BioAtla, Inc. | -103.73 Million USD | 312.187% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1929482.889% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 123753.933% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 190.645% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 70872.99% |
| XOMA Corporation | 3.86 Million USD | -5600.699% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 414.053% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1387.792% |
| aTyr Pharma, Inc. | -2.38 Million USD | 9317.085% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1666.485% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 759079.31% |
| Viridian Therapeutics, Inc. | -1 Million USD | 21935.714% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1693107592.308% |
| Akari Therapeutics, Plc | -4000.00 USD | 5502700.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 65.441% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -112943.121% |
| UroGen Pharma Ltd. | 73.35 Million USD | -200.065% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 924.545% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1895713.953% |
| Orgenesis Inc. | -5.72 Million USD | 3944.611% |
| Entera Bio Ltd. | -56 Thousand USD | 393142.857% |
| GH Research PLC | -315 Thousand USD | 69974.286% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 116557.143% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 42024.571% |
| Xencor, Inc. | -85.26 Million USD | 358.156% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 99704.936% |
| Replimune Group, Inc. | -2.65 Million USD | 8390.169% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 22083.229% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -23.762% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -112943.121% |
| Portage Biotech Inc. | -54 Thousand USD | 407700.0% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 232878.806% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 58483.024% |
| OncoCyte Corporation | 413 Thousand USD | -53193.947% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 4896740.712% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 99146045.946% |
| Purple Biotech Ltd. | -196 Thousand USD | 112397.959% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2354.326% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2150.092% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2207.275% |
| HilleVax, Inc. | -2.15 Million USD | 10308.905% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 227011.34% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1467068.808% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 33049.701% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 957073.913% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2932411.595% |
| Savara Inc. | -44.26 Million USD | 597.275% |
| Curis, Inc. | 9.81 Million USD | -2143.441% |
| Daré Bioscience, Inc. | 2.76 Million USD | -7847.364% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 176482.344% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 12830.133% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 96636.842% |
| BeiGene, Ltd. | 2.07 Billion USD | 89.412% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 7972.385% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 155.072% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -288.273% |
| Erasca, Inc. | -3.73 Million USD | 5997.749% |
| bluebird bio, Inc. | -4.03 Million USD | 5561.638% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 780112.758% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 88.442% |
| DBV Technologies S.A. | 15.72 Million USD | -1299.44% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 780112.758% |
| Moderna, Inc. | 2.15 Billion USD | 89.786% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 24155.082% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2649.238% |
| Molecular Templates, Inc. | 50.39 Million USD | -336.758% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 41164.179% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -64.517% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3637.512% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 659.449% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 298.063% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6234.448% |
| MacroGenics, Inc. | 50.52 Million USD | -335.617% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 3709.446% |
| Prime Medicine, Inc. | -147.9 Million USD | 248.814% |
| Aditxt, Inc. | -111.66 Thousand USD | 197219.828% |
| Adagene Inc. | 18.11 Million USD | -1115.273% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -45003.279% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -56.991% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -39.451% |
| SciSparc Ltd. | 2.19 Million USD | -9922.951% |
| Vericel Corporation | 135.57 Million USD | -62.347% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 878793.76% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 710525.408% |
| Generation Bio Co. | -73.91 Million USD | 397.796% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 50467.048% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -302.981% |
| Invivyd, Inc. | -2.02 Million USD | 10953.254% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 173.163% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 212888.337% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -128.399% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -123.938% |
| ADMA Biologics, Inc. | 88.21 Million USD | -149.5% |
| Clene Inc. | 533 Thousand USD | -41195.31% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -812.947% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 23099.373% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1162.239% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -10971.63% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 113371.167% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -341.932% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3203.553% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 26428.23% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -163.866% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -300950.443% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -314.025% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 227.09% |
| Trevena, Inc. | 1.45 Million USD | -15027.423% |
| Surrozen, Inc. | -27.23 Million USD | 908.314% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 62452.408% |
| Cingulate Inc. | -582.91 Thousand USD | 37858.999% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 710112.903% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1217.336% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2907682.563% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 25083.428% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 67.665% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 22377.733% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 390757.059% |
| Kronos Bio, Inc. | 1.37 Million USD | -15942.566% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 510.137% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 75478.082% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 45174.276% |
| ImmunityBio, Inc. | -17.89 Million USD | 1330.319% |
| Korro Bio, Inc. | -3.63 Million USD | 6163.471% |
| Kineta, Inc. | 5.43 Million USD | -3951.242% |
| BioVie Inc. | -229.37 Thousand USD | 96057.31% |
| Codexis, Inc. | 57.33 Million USD | -283.898% |
| Celularity Inc. | 6.75 Million USD | -3158.386% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5384.774% |
| Celcuity Inc. | -142.77 Thousand USD | 154264.682% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -434974.125% |
| Cibus, Inc. | 1.42 Million USD | -15378.481% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 58951.337% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1060.356% |
| IN8bio, Inc. | -2.5 Million USD | 8900.64% |
| Kodiak Sciences Inc. | -25.94 Million USD | 948.283% |
| Annexon, Inc. | -3.26 Million USD | 6837.19% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 10868.297% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 627.359% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -34291.25% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 71.728% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -27.261% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 11684.421% |
| Arcellx, Inc. | 108.27 Million USD | -103.275% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 779.984% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -177.895% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1140.582% |
| Moolec Science SA | -143.3 Thousand USD | 153691.291% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 620.119% |
| Geron Corporation | -123.5 Million USD | 278.218% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -6596.197% |
| Royalty Pharma plc | 1.79 Billion USD | 87.73% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 414.031% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6093787.708% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -95022.109% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 297.555% |
| Humacyte, Inc. | -76.55 Million USD | 387.53% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 23289.004% |
| 89bio, Inc. | -273 Thousand USD | 80724.176% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 17610.263% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 26055.66% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 179046.341% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -19569.705% |
| Notable Labs, Ltd. | 113 Thousand USD | -194682.301% |
| Liquidia Corporation | 14.6 Million USD | -1407.562% |
| Mustang Bio, Inc. | -2.22 Million USD | 9992.315% |
| Immunovant, Inc. | -231 Thousand USD | 95383.117% |
| Quantum-Si incorporated | 488 Thousand USD | -45003.279% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 496.163% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 733780.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -11720.838% |
| Acasti Pharma Inc. | -11 Thousand USD | 2001045.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 107668.775% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 34042.886% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 231.396% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -19299.602% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 57870.079% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 11341.267% |
| PepGen Inc. | -1.18 Million USD | 18689.865% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 173410.236% |
| United Therapeutics Corporation | 2.07 Billion USD | 89.367% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1061.279% |
| Solid Biosciences Inc. | -76.56 Million USD | 387.481% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 266624.587% |
| Immuneering Corporation | -764.13 Thousand USD | 28904.221% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -332062.26% |
| Belite Bio, Inc | -399 Thousand USD | 55263.91% |
| XOMA Corporation | 3.86 Million USD | -5600.699% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1198.543% |
| Bionomics Limited | -434.44 Thousand USD | 50762.794% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20593.855% |
| uniQure N.V. | 2.21 Million USD | -9836.975% |
| Cassava Sciences, Inc. | -89.42 Million USD | 346.138% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 339.064% |
| Forte Biosciences, Inc. | -9000.00 USD | 2445700.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 26459.76% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 50467.048% |
| Altimmune, Inc. | -65.37 Million USD | 436.689% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 39.203% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20593.855% |
| Compugen Ltd. | 31.45 Million USD | -599.742% |
| Peak Bio, Inc. | 367.76 Thousand USD | -59748.437% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -797.797% |
| Benitec Biopharma Inc. | 108 Thousand USD | -203700.0% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 282284.615% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 18396.259% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 12180.351% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 185061.345% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 18396.259% |
| Instil Bio, Inc. | -4.75 Million USD | 4727.923% |
| argenx SE | 1.1 Billion USD | 80.144% |
| Immunome, Inc. | -8.9 Million USD | 2571.135% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 11745.714% |
| Verona Pharma plc | -679.62 Thousand USD | 32486.143% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 125873.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 9328.679% |
| CervoMed Inc. | -1.29 Million USD | 17114.487% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 9244.329% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 4707.578% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -8807.487% |
| Moolec Science SA | -143.3 Thousand USD | 153691.291% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 54043.092% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 8338.881% |
| AnaptysBio, Inc. | 14.78 Million USD | -1389.101% |
| Design Therapeutics, Inc. | -537 Thousand USD | 41087.709% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 51646.604% |
| NeurAxis, Inc. | 2.15 Million USD | -10105.573% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -10156.477% |
| Lumos Pharma, Inc. | 2 Million USD | -10866.816% |
| Achilles Therapeutics plc | -4.73 Million USD | 4752.115% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 125873.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 208383.889% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -595.239% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -25430.997% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 21427.907% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 583.235% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -511769.767% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 26876.642% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1672877.018% |
| Palisade Bio, Inc. | 246 Thousand USD | -89373.171% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 667081.818% |
| Beam Therapeutics Inc. | -59.67 Million USD | 468.856% |
| Neurogene Inc. | -3.26 Million USD | 6847.517% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -57.967% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6061.647% |
| Sesen Bio, Inc. | 40 Million USD | -450.26% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 74209.091% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 5565.656% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2400.899% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1463.239% |
| Athira Pharma, Inc. | -969 Thousand USD | 22814.551% |
| Vaccinex, Inc. | -16 Million USD | 1475.306% |
| HCW Biologics Inc. | -574.82 Thousand USD | 38390.677% |
| XOMA Corporation | 3.86 Million USD | -5600.699% |
| Nektar Therapeutics | 53.47 Million USD | -311.579% |
| Arvinas, Inc. | 71.8 Million USD | -206.552% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 363.721% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 450.624% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 68455.28% |
| Rezolute, Inc. | -36 Thousand USD | 611500.0% |
| Clene Inc. | 533 Thousand USD | -41195.31% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 17142156.075% |
| BeyondSpring Inc. | 1.75 Million USD | -12470.188% |
| Synlogic, Inc. | -1.92 Million USD | 11539.917% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 594975.676% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3576.058% |
| Peak Bio, Inc. | 367.76 Thousand USD | -59748.437% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1260.702% |
| Krystal Biotech, Inc. | 47.6 Million USD | -362.355% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -56.001% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4280.179% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 8600.787% |
| MannKind Corporation | 136.19 Million USD | -61.614% |
| Ikena Oncology, Inc. | -50.49 Million USD | 535.919% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -102.275% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5119.475% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 87442.857% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4402180.0% |
| Legend Biotech Corporation | 140.92 Million USD | -56.181% |
| Mural Oncology plc | -2.56 Million USD | 8674.367% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 40046.279% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 220204.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -960.538% |
| REGENXBIO Inc. | 53.02 Million USD | -315.063% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4208.754% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 114514.035% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 12808.083% |
| Vaxart, Inc. | -60.76 Million USD | 462.234% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 83859.799% |
| Cellectis S.A. | 18 Thousand USD | -1222700.0% |
| Longeveron Inc. | 221 Thousand USD | -99494.57% |
| Repare Therapeutics Inc. | -80.07 Million USD | 374.889% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 79.862% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 17109.583% |
| Revolution Medicines, Inc. | -399.66 Million USD | 155.072% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 628968.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -449091.837% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.443% |
| Denali Therapeutics Inc. | -93.34 Million USD | 335.796% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 878793.76% |
| Veru Inc. | 7.56 Million USD | -2809.147% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 145864.238% |
| Cingulate Inc. | -582.91 Thousand USD | 37858.999% |
| Passage Bio, Inc. | -3.72 Million USD | 6015.184% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1827599.17% |
| Exicure, Inc. | -1.42 Million USD | 15567.604% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 57568.407% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -8042.952% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 43032.462% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -223.084% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 147221.458% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 471.76% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -56192.583% |
| OmniAb, Inc. | 14.66 Million USD | -1400.675% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1000.905% |
| Lipocine Inc. | -2.85 Million USD | 7820.731% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 12042.702% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 3958.089% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14712.316% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -192.241% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 338721.538% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -161.108% |
| Ocugen, Inc. | -33.53 Million USD | 756.302% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7060.911% |
| Q32 Bio Inc. | 578 Thousand USD | -37980.277% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 83158.113% |
| Alumis Inc. Common Stock | -1.28 Million USD | 17242.056% |
| Equillium, Inc. | 35.95 Million USD | -512.114% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 12994.2% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -43861.101% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5324338.026% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 85082.239% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -51969.494% |
| Dominari Holdings Inc. | 2.03 Million USD | -10694.703% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 120066.643% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1719.007% |
| Bio-Techne Corporation | 773.07 Million USD | 71.529% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1170.882% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 52.233% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 18928.4% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1017.865% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1781.713% |
| Nkarta, Inc. | -5.86 Million USD | 3850.281% |
| BioCardia, Inc. | -7.24 Million USD | 3136.336% |
| Iterum Therapeutics plc | -1.75 Million USD | 12677.371% |